Navigation Links
Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
Date:9/14/2007

CHARLIE ROSE SCIENCE SERIES Episode #9 - HEART DISEASE September 19, 2007

NEW YORK, Sept. 14 /PRNewswire/ -- The following is being issued by Pfizer Inc:

WHAT: The upcoming episode of the Charlie Rose Science Series will

discuss the global burden of cardiovascular disease, the leading

cause of mortality worldwide. A panel of experts will explore the

biology and genetics of the disease, prevention and treatment, the

development of medical, surgical and interventional therapies, and

steps individuals can take toward a heart-healthy lifestyle.

WHO: Guests will include:

-- Steven E. Nissen, MD, MACC, Chairman of Cleveland Clinic

Department of Cardiovascular Medicine

-- Lori Mosca, MD, MPH, PhD, Director of Preventive Cardiology, New

York Presbyterian Hospital

-- Harlan Krumholz, MD, Harold H. Hines Junior Professor of Medicine

and Epidemiology and Public Health, Yale University School of

Medicine

-- Lance Becker, MD, Director of the Center for Resuscitation

Science at the University of Pennsylvania

WHEN: Begins Airing on September 19, 2007 on PBS stations. Check your

local PBS listings for show times.

DESCRIPTION:

The Charlie Rose Science Series sponsored by Pfizer Inc is an exploration of modern advances in scientific research, their contribution to our understanding of the world around us, and how science breakthroughs can be applied to improving human health.

Charlie Rose is joined in this effort by his co-host, Sir Paul Nurse, PhD, Nobel Laureate and President of Rockefeller University.

As a world leader in research and development, Pfizer is committed to increasing public understanding of science and science education. For more information about The Charlie Rose Science Series or to watch clips from past episodes, please visit http://www.charlierose.com.


'/>"/>
SOURCE Pfizer Inc
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Flat panel displays
2. Panel stresses drawing outside biotech firms to state
3. National stem-cell panel, including UW profs, urges close watch on research
4. Star panel re-evaluates Sarbanes-Oxley one year in at SEC headquarters
5. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
6. VC trends, company progress discussed at Mason Wells portfolio meeting
7. Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths
8. State CIO discusses IT and government
9. Industry Veterans discuss the "next big thing"
10. Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment
11. Wisconsin Leaders Discuss Economic Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... instruments and applications consulting for microscopy and surface analysis, Nanoscience Instruments is ... Nanoscience Analytical offers a broad range of contract analysis services for advanced ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):